Plain-English translation of NCT06960252 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new catheter called the OPTRELL Mapping Catheter to help doctors better understand and treat persistent atrial fibrillation—a condition where your heart beats irregularly and doesn't respond well to standard medications. The catheter creates detailed maps of your heart to identify the sources of the irregular rhythm, which doctors can then target with radiofrequency ablation (a minimally invasive procedure that uses heat to fix problem areas).
Standard treatment for persistent atrial fibrillation often doesn't work well enough for many patients. Research suggests that mapping the heart in more detail and targeting specific problem areas—rather than just treating one part of the heart—might help more patients return to a normal heartbeat and feel better.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for a catheter ablation procedure where doctors use the new OPTRELL mapping catheter to create detailed maps of your heart while it's in an irregular rhythm. This helps them identify the exact areas causing the problem. Doctors then use radiofrequency energy to treat those specific areas. You would need to attend follow-up visits to see how well the procedure worked for controlling your irregular heartbeat.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Taiwan